Aspen Neuroscience Featured in the Wall Street Journal

Aspen Neuroscience is excited to be featured, and very proud of the progress we’ve made to advance the science. Thank you to the Wall Street Journal for providing focus to iPSCs.

The article can be found here: https://www.wsj.com/articles/stem-cells-parkinsons-disease-heart-failure-60e9e21f?st=noc464icymdkvso&reflink=desktopwebshare_permalink

Please note that we at Aspen Neuroscience do not make determinations on who would be eligible for participation in clinical trials, and we do not offer tours of our laboratory. At this time, our therapy has not yet been used in humans and clinical trials have not begun.